| Record ID | marc_columbia/Columbia-extract-20221130-010.mrc:290168467:3364 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-010.mrc:290168467:3364?format=raw |
LEADER: 03364cam a22004574a 4500
001 4770355
005 20221103033535.0
008 040219t20042004maua b 001 0 eng
010 $a 2004044222
016 7 $a101207334$2DNLM
020 $a1402078080 (alk. paper)
035 $a(OCoLC)ocm54501470
035 $a(NNC)4770355
035 $a4770355
040 $aDNLM/DLC$cDLC$dNLM$dC#P$dOrLoB-B
042 $apcc
050 00 $aRC280.S66$bT37 2004
060 0 $aW1$bCA693 v.120 2004
060 10 $aQZ 345$bT185 2004
082 00 $a616.99/4$222
245 00 $aTargeting treatment of soft tissue sarcomas /$cedited by Jaap Verweij and Herbert M. Pinedo.
260 $aBoston :$bKluwer Academic Publishers,$c[2004], ©2004.
300 $a184 pages :$billustrations ;$c25 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aCancer treatment and research ;$v120
504 $aIncludes bibliographical references and index.
505 00 $g1.$tTargeted therapy : ready for prime time? /$rC. Seynaeve and J. Verweij -- $g2.$tVolume-based radiotherapy targeting in soft tissue sarcoma /$rIain Ward, Tara Haycocks, Michael Sharpe, Anthony Griffin, Charles Catton, David Jaffray and Brian O'Sullivan -- $g3.$tPreoperative therapy for soft tissue sarcoma /$rJanice N. Cormier, Howard N. Langstein and Peter W. T. Pisters -- $g4.$tTNF-based isolated limb perfusion : a decade of experience with antivascular therapy in the management of locally advanced extremity soft tissue sarcomas /$rDirk J. Grunhagen, Flavia Brunstein, Timo L. M. ten Hagen, Albertus N. van Geel, Johannes H. W. de Wilt and Alexander M. M. Eggermont -- $g5.$tPitfalls in pathology of soft tissue sarcomas /$rJudith V. M. G. Bovee and Pancras C. W. Hogendoorn -- $g6.$tMolecular biology and cytogenetics of soft tissue sarcomas : relevance for targeted therapies /$rJonathan Fletcher -- $g7.$tKIT and PDGF as targets /$rJaap Verweij -- $g8.$tTargeting mutant kinases in gastrointestinal stromal tumors : a paradigm for molecular therapy of other sarcomas /$rMike C. Heinrich and Christopher L. Corless -- $g9.$tTargeting other abnormal signalling pathways in sarcoma : EGFR in synovial sarcomas, PPAR-[gamma] in liposarcoma /$rJean-Yves Blay, Isabelle Ray-Coquard, Laurent Alberti and Dominique Ranchere -- $g10.$tAngiogenesis : a potential target for therapy of soft tissue sarcomas /$rK. Hoekman and H. M. Pinedo.
650 0 $aSoft tissue tumors$xTreatment.
650 0 $aSarcoma$xTreatment.
650 0 $aDrug targeting.$0http://id.loc.gov/authorities/subjects/sh88005350
650 12 $aSarcoma$xtherapy.$0https://id.nlm.nih.gov/mesh/D012509Q000628
650 22 $aAntineoplastic Agents.$0https://id.nlm.nih.gov/mesh/D000970
650 22 $aDrug Delivery Systems$xmethods.$0https://id.nlm.nih.gov/mesh/D016503Q000379
650 22 $aGrowth Substances.$0https://id.nlm.nih.gov/mesh/D006133
650 22 $aReceptors, Growth Factor.$0https://id.nlm.nih.gov/mesh/D017978
650 22 $aSarcoma$xphysiopathology.$0https://id.nlm.nih.gov/mesh/D012509Q000503
700 1 $aVerweij, J.$q(Jaap)$0http://id.loc.gov/authorities/names/n85276405
700 1 $aPinedo, H. M.$0http://id.loc.gov/authorities/names/n78080586
830 0 $aCancer treatment and research ;$vv. 120.$0http://id.loc.gov/authorities/names/n42005764
852 00 $boff,hsl$hRC280.S66$iT37 2004